Literature DB >> 29912718

Pulmonary Sarcomatoid Carcinomas: A Review.

Annikka Weissferdt1.   

Abstract

Pulmonary sarcomatoid carcinomas belong to a group of neoplasms that remain incompletely understood. They are rare tumors of the bronchopulmonary system that incorporate a wide range of neoplasms that by definition contain a sarcomatoid component characterized by spindle or giant cells. Such classification has led to a heterogenous tumor category that includes neoplasms with different clinical, morphologic, and prognostic features. To date, the histopathologic diagnosis of pulmonary sarcomatoid carcinomas does not require the use of ancillary testing and is based on light microscopic criteria alone. However, with recent advances in immunohistochemical and molecular methods, it is becoming increasingly clear that pulmonary sarcomatoid carcinomas represent poorly differentiated or "dedifferentiated" variants of conventional non-small cell carcinomas with similar immunophenotype and molecular signatures. This review summarizes the latest insights and concepts of these unusual tumors and outlines future directions with emphasis on tumor classification and patient management.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29912718     DOI: 10.1097/PAP.0000000000000202

Source DB:  PubMed          Journal:  Adv Anat Pathol        ISSN: 1072-4109            Impact factor:   3.875


  13 in total

1.  Omega-6 Polyunsaturated Fatty Acids Enhance Tumor Aggressiveness in Experimental Lung Cancer Model: Important Role of Oxylipins.

Authors:  Mayra Montecillo-Aguado; Belen Tirado-Rodriguez; Gabriela Antonio-Andres; Mario Morales-Martinez; Zhen Tong; Jun Yang; Bruce D Hammock; Rogelio Hernandez-Pando; Sara Huerta-Yepez
Journal:  Int J Mol Sci       Date:  2022-05-31       Impact factor: 6.208

2.  Dramatic Response of Pulmonary Sarcomatoid Carcinoma to Nivolumab Combined with Anlotinib: A Case Report.

Authors:  Caibao Jin; Bin Yang
Journal:  Case Rep Oncol       Date:  2020-06-04

3.  Additional chemotherapy improves survival in stage II-III pulmonary sarcomatoid carcinoma patients undergoing surgery: a propensity scoring matching analysis.

Authors:  Yanhong Cen; Chunxu Yang; Jiangbo Ren; Yan Gong; Conghua Xie
Journal:  Ann Transl Med       Date:  2021-01

4.  Pulmonary sarcomatoid carcinoma mimicking pleural mesothelioma: A case report.

Authors:  Le Wang; Jing Zhang; Xing Chen; Maoli Liang; Shuo Li; Wei Zhou; Jie Cao
Journal:  Medicine (Baltimore)       Date:  2021-11-12       Impact factor: 1.817

5.  Establishment of a Competing Risk Nomogram in Patients with Pulmonary Sarcomatoid Carcinoma.

Authors:  Ziwei Liang; Enyu Zhang; Ling Duan; Nathaniel Weygant; Guangyu An; Bin Hu; Jiannan Yao
Journal:  Technol Cancer Res Treat       Date:  2022 Jan-Dec

6.  Pten and p53 Loss in the Mouse Lung Causes Adenocarcinoma and Sarcomatoid Carcinoma.

Authors:  Sara Lázaro; Corina Lorz; Ana Belén Enguita; Iván Seller; Jesús M Paramio; Mirentxu Santos
Journal:  Cancers (Basel)       Date:  2022-07-28       Impact factor: 6.575

7.  Development and validation of a prognostic predictive model of pulmonary spindle cell carcinoma from the surveillance, epidemiology and end results database.

Authors:  Wei Li; Minghang Zhang; Siyun Fu; Xuefeng Hao; Liwei Song; Jinghui Wang; Bin Liu; Shaofa Xu
Journal:  Transl Cancer Res       Date:  2022-08       Impact factor: 0.496

Review 8.  First-line albumin-bound paclitaxel/carboplatin plus apatinib in advanced pulmonary sarcomatoid carcinoma: A case series and review of the literature.

Authors:  Feng-Wei Kong; Wei-Min Wang; Lei Liu; Wen-Bin Wu; Xiang Wang; Miao Zhang
Journal:  Medicine (Baltimore)       Date:  2020-06-05       Impact factor: 1.817

9.  Gingival metastasis of a mediastinal pulmonary sarcomatoid carcinoma: a case report.

Authors:  Zhonghua Qin; Bin Huang; Guiping Yu; Yongqiang Zheng; Ke Zhao
Journal:  J Cardiothorac Surg       Date:  2019-09-09       Impact factor: 1.637

10.  Response to crizotinib in a patient with metastatic lung spindle cell carcinoma harboring TPM3-ROS1 fusion.

Authors:  Cun-Liang Cai; Ming-Qiang Zhang; Jun Guo; Li-Wan Wang; Jing-Quan Zhao; Wen-Jia Guo; Xiang-Dong Mu
Journal:  Chin Med J (Engl)       Date:  2019-12-20       Impact factor: 2.628

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.